See more : LegoChem Biosciences, Inc. (141080.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of Helix BioMedix, Inc. (HXBM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Helix BioMedix, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Karnov Group AB (publ) (0A39.L) Income Statement Analysis – Financial Results
- Barton Gold Holdings Limited (BGD.AX) Income Statement Analysis – Financial Results
- PT Kedawung Setia Industrial Tbk (KDSI.JK) Income Statement Analysis – Financial Results
- IDream Film Infrastructure Company Limited (SOFTBPO.BO) Income Statement Analysis – Financial Results
- Kalyani Investment Company Limited (KICL.NS) Income Statement Analysis – Financial Results
Helix BioMedix, Inc. (HXBM)
About Helix BioMedix, Inc.
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
| Metric | 2023 | 2022 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 997.73K | 1.75M | 1.89M | 851.68K | 391.27K | 562.88K | 463.94K | 70.94K |
| Cost of Revenue | 9.75K | 15.57K | 842.48K | 374.27K | 327.12K | 389.13K | 312.72K | 343.75K |
| Gross Profit | 987.98K | 1.74M | 1.05M | 477.41K | 64.15K | 173.75K | 151.22K | -272.81K |
| Gross Profit Ratio | 99.02% | 99.11% | 55.46% | 56.06% | 16.40% | 30.87% | 32.60% | -384.56% |
| Research & Development | 317.06K | 891.96K | 501.04K | 748.66K | 722.52K | 827.36K | 782.08K | 988.45K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.65M | 1.93M | 2.95M | 2.68M | 1.98M | 2.32M | 2.35M | 2.31M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -579.44K | -570.72K | -537.18K | -332.88K |
| Operating Expenses | 1.97M | 2.82M | 3.45M | 3.43M | 3.28M | 3.72M | 3.67M | 3.63M |
| Cost & Expenses | 1.98M | 2.83M | 4.30M | 3.81M | 3.61M | 4.11M | 3.98M | 3.97M |
| Interest Income | 51.40K | 2.90K | 3.73K | 3.07K | 9.65K | 60.84K | 84.58K | 74.61K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 673.44K | 485.52K | 1.04M | 0.00 | 0.00 |
| Depreciation & Amortization | 9.75K | 12.72K | 109.18K | 113.78K | 130.60K | 133.75K | 174.23K | 180.76K |
| EBITDA | -1.05M | -1.18M | -2.30M | -2.84M | -3.09M | -3.41M | -3.34M | -3.72M |
| EBITDA Ratio | -104.87% | -60.76% | -121.35% | -333.74% | -789.05% | -605.89% | -720.86% | -5,245.28% |
| Operating Income | -984.05K | -1.08M | -2.40M | -2.96M | -3.22M | -3.54M | -3.52M | -3.90M |
| Operating Income Ratio | -98.63% | -61.48% | -127.12% | -347.10% | -822.43% | -629.65% | -758.41% | -5,500.08% |
| Total Other Income/Expenses | -72.00K | -113.34K | -84.25K | -4.75M | -557.13K | -971.33K | 84.58K | 73.43K |
| Income Before Tax | -1.06M | -1.19M | -2.49M | -7.71M | -3.78M | -4.52M | -3.43M | -3.83M |
| Income Before Tax Ratio | -105.85% | -67.94% | -131.58% | -905.36% | -964.82% | -802.22% | -740.18% | -5,396.57% |
| Income Tax Expense | 5.00 | -1.00 | 5.00 | 3.00 | 5.00 | -4.00 | -5.00 | 5.00 |
| Net Income | -1.06M | -1.19M | -2.49M | -7.71M | -3.78M | -4.52M | -3.43M | -3.83M |
| Net Income Ratio | -105.85% | -67.94% | -131.58% | -905.36% | -964.82% | -802.22% | -740.18% | -5,396.57% |
| EPS | -4.70 | -5.31 | -15.02 | -85.28 | -44.15 | -52.81 | -40.98 | -51.40 |
| EPS Diluted | -4.70 | -5.31 | -15.02 | -85.28 | -44.15 | -52.81 | -40.98 | -51.40 |
| Weighted Avg Shares Out | 224.71K | 224.71K | 165.73K | 90.41K | 85.51K | 85.51K | 83.80K | 74.48K |
| Weighted Avg Shares Out (Dil) | 224.71K | 224.71K | 165.73K | 90.41K | 85.51K | 85.51K | 83.80K | 74.48K |
Source: https://incomestatements.info
Category: Stock Reports